The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm | Journal of Nuclear Medicine
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Antibodies + CAR-T Cells - Gene Center Munich - LMU Munich
T cell activation - Antineo
Vaccines | Free Full-Text | B-Cell-Based Immunotherapy: A Promising New Alternative
Frontiers | γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Overcoming the challenges associated with CD3+ T-cell redirection in cancer | British Journal of Cancer
Antibodies | Free Full-Text | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
Expanding roles for CD4+ T cells in immunity to viruses | Nature Reviews Immunology
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers | ACS Synthetic Biology
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV: Molecular Therapy - Methods & Clinical Development
Pathogen manipulation of B cells: the best defence is a good offence | Nature Reviews Microbiology
Not just antibodies: B cells and T cells mediate immunity to COVID-19 | Nature Reviews Immunology
An Introduction to Antibodies: Antigens, Epitopes and Antibodies
Imaging of Activated T Cells | Journal of Nuclear Medicine
What is the role of T cells in COVID-19 infection? Why immunity is about more than antibodies - The Centre for Evidence-Based Medicine
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation: Molecular Therapy
The Search for Immune Responses that Stop COVID-19 | The Scientist Magazine®
IJMS | Free Full-Text | Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells: Molecular Therapy - Methods & Clinical Development
Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
Frontiers | Nanodrugs Targeting T Cells in Tumor Therapy
More on T Cells, Antibody Levels, and Our Ignorance | Science | AAAS
Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing - Ontario COVID-19 Science Advisory Table
Antibodies | Free Full-Text | Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
